| Symbol | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 12, 2015 | Option Exercise | $8.68 | 4,000 | 34,720 | 107,328 | Dec 15, 2015, 05:12 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 11, 2015 | Option Exercise | $8.68 | 4,348 | 37,741 | 111,328 | Dec 15, 2015, 05:12 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 07, 2015 | Option Exercise | $9.69 | 6,087 | 58,983 | 115,676 | Dec 09, 2015, 04:53 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jun 05, 2015 | Option Exercise | $3.45 | 15,000 | 51,750 | 111,763 | Jun 09, 2015, 05:26 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jun 05, 2015 | Sale | $12.29 | 15,000 | 184,394 | 96,763 | Jun 09, 2015, 05:26 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 05, 2015 | Option Exercise | $3.45 | 15,000 | 51,750 | 110,376 | May 05, 2015, 07:26 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 05, 2015 | Sale | $12.29 | 15,000 | 184,297 | 95,376 | May 05, 2015, 07:26 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 06, 2015 | Option Exercise | $3.45 | 15,000 | 51,750 | 110,376 | Apr 08, 2015, 07:06 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 06, 2015 | Sale | $14.94 | 15,000 | 224,172 | 95,376 | Apr 08, 2015, 07:06 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 05, 2015 | Option Exercise | $3.45 | 15,000 | 51,750 | 110,376 | Mar 06, 2015, 06:49 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 05, 2015 | Sale | $18.29 | 15,000 | 274,282 | 95,376 | Mar 06, 2015, 06:49 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 05, 2015 | Option Exercise | $6.10 | 15,000 | 91,509 | 110,376 | Feb 06, 2015, 07:50 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 05, 2015 | Sale | $12.93 | 15,000 | 193,950 | 95,376 | Feb 06, 2015, 07:50 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 05, 2015 | Option Exercise | $6.82 | 15,000 | 102,300 | 110,376 | Jan 06, 2015, 07:24 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 05, 2015 | Sale | $15.19 | 15,000 | 227,854 | 95,976 | Jan 06, 2015, 07:24 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 15, 2014 | Option Exercise | $14.74 | 27,480 | 405,006 | 95,376 | Dec 15, 2014, 09:23 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 05, 2014 | Option Exercise | $6.82 | 15,000 | 102,300 | 112,856 | Dec 09, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 05, 2014 | Sale | $11.21 | 15,000 | 168,197 | 97,856 | Dec 09, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 05, 2014 | Option Exercise | $5.59 | 15,000 | 83,877 | 112,856 | Nov 07, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 05, 2014 | Sale | $11.35 | 15,000 | 170,258 | 97,856 | Nov 07, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 06, 2014 | Option Exercise | $4.11 | 15,000 | 61,650 | 111,579 | Oct 08, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 06, 2014 | Sale | $10.72 | 15,000 | 160,865 | 96,579 | Oct 08, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2014 | Option Exercise | $4.11 | 15,000 | 61,650 | 111,579 | Sep 05, 2014, 09:45 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2014 | Sale | $12.20 | 15,000 | 183,072 | 96,579 | Sep 05, 2014, 09:45 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 05, 2014 | Option Exercise | $4.11 | 13,202 | 54,260 | 111,579 | Aug 05, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 05, 2014 | Sale | $12.99 | 15,000 | 194,846 | 98,377 | Aug 05, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 27, 2014 | Option Exercise | $3.68 | 15,000 | 55,230 | 111,377 | May 29, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 27, 2014 | Sale | $13.57 | 15,000 | 203,531 | 98,377 | May 29, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 28, 2014 | Option Exercise | $3.68 | 15,000 | 55,230 | 110,015 | Apr 30, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 28, 2014 | Sale | $13.64 | 15,000 | 204,532 | 97,015 | Apr 30, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2014 | Option Exercise | $3.68 | 15,000 | 55,230 | 110,015 | Mar 28, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2014 | Sale | $18.65 | 15,000 | 279,695 | 97,215 | Mar 28, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2014 | Option Exercise | $3.68 | 15,000 | 55,230 | 110,015 | Feb 28, 2014, 08:01 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2014 | Sale | $19.72 | 15,000 | 295,752 | 97,015 | Feb 28, 2014, 08:01 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 27, 2014 | Option Exercise | $3.68 | 15,000 | 55,230 | 110,015 | Jan 29, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 27, 2014 | Sale | $18.58 | 15,000 | 278,729 | 97,015 | Jan 29, 2014, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2013 | Option Exercise | $3.68 | 15,000 | 55,230 | 110,015 | Dec 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2013 | Sale | $14.37 | 15,000 | 215,477 | 97,015 | Dec 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 12, 2013 | Option Exercise | $12.12 | 14,783 | 179,170 | 97,015 | Dec 13, 2013, 08:03 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2013 | Option Exercise | $3.90 | 15,000 | 58,570 | 100,798 | Nov 29, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2013 | Sale | $11.83 | 15,000 | 177,378 | 88,798 | Nov 29, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 28, 2013 | Option Exercise | $3.90 | 15,000 | 58,570 | 98,798 | Oct 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 28, 2013 | Sale | $10.39 | 15,000 | 155,779 | 86,798 | Oct 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 26, 2013 | Option Exercise | $3.90 | 15,000 | 58,570 | 96,798 | Sep 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 26, 2013 | Sale | $10.57 | 15,000 | 158,574 | 84,798 | Sep 30, 2013, 08:00 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 26, 2013 | Option Exercise | $3.84 | 13,000 | 49,930 | 97,798 | Aug 28, 2013, 08:01 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 26, 2013 | Sale | $10.04 | 15,000 | 150,606 | 86,798 | Aug 28, 2013, 08:01 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2013 | Option Exercise | $3.84 | 13,000 | 49,930 | 99,798 | Jul 30, 2013, 04:20 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2013 | Sale | $10.09 | 15,000 | 151,308 | 88,798 | Jul 30, 2013, 04:20 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 28, 2013 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | May 30, 2013, 04:31 PM |
| SGMO | VP, Therapeutic Dev. & CMO | May 28, 2013 | Sale | $8.32 | 15,000 | 124,818 | 88,798 | May 30, 2013, 04:31 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 26, 2013 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Apr 29, 2013, 06:16 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 26, 2013 | Sale | $10.72 | 15,000 | 160,746 | 88,798 | Apr 29, 2013, 06:16 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2013 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Mar 28, 2013, 05:44 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2013 | Sale | $9.18 | 15,000 | 137,724 | 88,798 | Mar 28, 2013, 05:44 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2013 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Feb 28, 2013, 06:15 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2013 | Sale | $8.64 | 15,000 | 129,600 | 88,798 | Feb 28, 2013, 06:15 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2013 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Feb 28, 2013, 06:11 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2013 | Sale | $9.68 | 15,000 | 145,158 | 88,798 | Feb 28, 2013, 06:11 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Jan 30, 2013, 04:17 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2012 | Sale | $9.68 | 15,000 | 145,158 | 88,798 | Jan 30, 2013, 04:17 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 103,798 | Dec 28, 2012, 04:06 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2012 | Sale | $5.92 | 17,000 | 100,718 | 88,798 | Dec 28, 2012, 04:06 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 27, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 70,798 | Nov 28, 2012, 07:35 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 27, 2012 | Sale | $5.60 | 15,000 | 84,000 | 55,798 | Nov 28, 2012, 07:35 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2012 | Sale | $5.33 | 4,736 | 25,232 | 55,798 | Nov 28, 2012, 07:35 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 26, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 78,534 | Oct 29, 2012, 09:53 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 26, 2012 | Sale | $5.70 | 20,000 | 113,935 | 63,534 | Oct 29, 2012, 09:53 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 15, 2012 | Sale | $5.66 | 5,000 | 28,283 | 67,534 | Oct 17, 2012, 05:58 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 83,534 | Sep 06, 2012, 05:51 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2012 | Sale | $5.60 | 15,000 | 84,000 | 68,534 | Sep 06, 2012, 05:51 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 27, 2012 | Sale | $5.18 | 5,000 | 25,903 | 72,364 | Aug 29, 2012, 07:07 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 27, 2012 | Option Exercise | $3.61 | 15,000 | 54,150 | 88,534 | Jul 30, 2012, 04:58 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 27, 2012 | Sale | $5.60 | 15,000 | 84,000 | 73,534 | Jul 30, 2012, 04:58 PM |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2012 | Sale | $5.06 | 5,000 | 25,320 | 77,534 | Jul 30, 2012, 04:58 PM |
| Symbol | Relationship | Date | Transaction | Value($) |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 12, 2015 | Option Exercise | 34,720 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 11, 2015 | Option Exercise | 37,741 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 07, 2015 | Option Exercise | 58,983 |
| SGMO | VP, Therapeutic Dev. & CMO | Jun 05, 2015 | Option Exercise | 51,750 |
| SGMO | VP, Therapeutic Dev. & CMO | Jun 05, 2015 | Sale | 184,394 |
| SGMO | VP, Therapeutic Dev. & CMO | May 05, 2015 | Option Exercise | 51,750 |
| SGMO | VP, Therapeutic Dev. & CMO | May 05, 2015 | Sale | 184,297 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 06, 2015 | Option Exercise | 51,750 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 06, 2015 | Sale | 224,172 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 05, 2015 | Option Exercise | 51,750 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 05, 2015 | Sale | 274,282 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 05, 2015 | Option Exercise | 91,509 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 05, 2015 | Sale | 193,950 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 05, 2015 | Option Exercise | 102,300 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 05, 2015 | Sale | 227,854 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 15, 2014 | Option Exercise | 405,006 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 05, 2014 | Option Exercise | 102,300 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 05, 2014 | Sale | 168,197 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 05, 2014 | Option Exercise | 83,877 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 05, 2014 | Sale | 170,258 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 06, 2014 | Option Exercise | 61,650 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 06, 2014 | Sale | 160,865 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2014 | Option Exercise | 61,650 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2014 | Sale | 183,072 |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 05, 2014 | Option Exercise | 54,260 |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 05, 2014 | Sale | 194,846 |
| SGMO | VP, Therapeutic Dev. & CMO | May 27, 2014 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | May 27, 2014 | Sale | 203,531 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 28, 2014 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 28, 2014 | Sale | 204,532 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2014 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2014 | Sale | 279,695 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2014 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2014 | Sale | 295,752 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 27, 2014 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 27, 2014 | Sale | 278,729 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2013 | Option Exercise | 55,230 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2013 | Sale | 215,477 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 12, 2013 | Option Exercise | 179,170 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2013 | Option Exercise | 58,570 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2013 | Sale | 177,378 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 28, 2013 | Option Exercise | 58,570 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 28, 2013 | Sale | 155,779 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 26, 2013 | Option Exercise | 58,570 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 26, 2013 | Sale | 158,574 |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 26, 2013 | Option Exercise | 49,930 |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 26, 2013 | Sale | 150,606 |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2013 | Option Exercise | 49,930 |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2013 | Sale | 151,308 |
| SGMO | VP, Therapeutic Dev. & CMO | May 28, 2013 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | May 28, 2013 | Sale | 124,818 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 26, 2013 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Apr 26, 2013 | Sale | 160,746 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2013 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Mar 26, 2013 | Sale | 137,724 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2013 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Feb 26, 2013 | Sale | 129,600 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2013 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2013 | Sale | 145,158 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Jan 28, 2012 | Sale | 145,158 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Dec 26, 2012 | Sale | 100,718 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 27, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 27, 2012 | Sale | 84,000 |
| SGMO | VP, Therapeutic Dev. & CMO | Nov 26, 2012 | Sale | 25,232 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 26, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 26, 2012 | Sale | 113,935 |
| SGMO | VP, Therapeutic Dev. & CMO | Oct 15, 2012 | Sale | 28,283 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Sep 05, 2012 | Sale | 84,000 |
| SGMO | VP, Therapeutic Dev. & CMO | Aug 27, 2012 | Sale | 25,903 |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 27, 2012 | Option Exercise | 54,150 |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 27, 2012 | Sale | 84,000 |
| SGMO | VP, Therapeutic Dev. & CMO | Jul 26, 2012 | Sale | 25,320 |